| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $121.19 | $23.81 | 409.07% | 228.66x | 57.68x | 15.37x | 18.56x | 1.66x | $106.92M | 0.84% | $705.78M | 6.70 | $13.00B | 1,656.96 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.58 | $8.13 | 226.81% | 126.57x | 59.42x | 7.48x | 15.15x | 1.08x | $39.15M | 1.13% | $220.58M | 1.69 | $3.42B | 75.35 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $79.78 | $17.15 | 365.16% | 74.56x | 68.25x | 7.36x | 9.52x | 1.90x | $182.84M | 2.95% | $654.15M | 8.43 | $6.06B | 50.50 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $232.68 | $79.68 | 192.01% | 38.14x | 34.51x | 6.47x | 22.99x | 1.31x | $793.95M | 2.55% | $1.35B | 10.14 | $32.41B | 27.48 | ||
| VCEL | VERICEL CORP | $40.10 | $7.92 | 406.50% | 83.54x | 71.65x | 6.69x | 5.55x | 2.05x | $61.66M | 3.01% | $370.04M | 7.25 | $2.02B | 45.87 | ||
| KRYS | KRYSTAL BIOTECH INC | $331.61 | $83.15 | 298.83% | 40.10x | 42.48x | 22.23x | 7.22x | 2.14x | $257.78M | 2.63% | $1.36B | 46.03 | $9.40B | 40.28 | ||
| RPRX | ROYALTY PHARMA PLC | $56.93 | $35.83 | 58.90% | 30.28x | 10.41x | 9.99x | 3.35x | 0.61x | $2.92B | 11.54% | $9.79B | 21.99 | $40.88B | 34.76 | ||
| HALO | HALOZYME THERAPEUTICS INC | $110.42 | $70.47 | 56.70% | 31.02x | 12.23x | 7.78x | 87.31x | 0.60x | $806.22M | 6.23% | $143.54M | 1.22 | $14.52B | 20.20 | ||
| TGTX | TG THERAPEUTICS INC | $55.37 | $22.20 | 149.40% | 17.98x | 55.72x | 9.82x | 14.03x | 2.00x | $17.39M | 0.22% | $604.08M | 4.26 | $8.74B | 62.81 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.80 | $18.45 | 196.94% | 144.20x | 18.94x | 3.11x | 1.68x | 0.96x | $738.18M | 6.96% | $6.32B | 32.68 | $13.92B | 36.09 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.39 | $7.54 | 51.12% | 11.99x | 10.47x | 4.95x | 3.11x | 1.05x | $82.01M | 12.17% | $217.65M | 3.68 | $532.56M | 6.89 | ||
| ADMA | ADMA BIOLOGICS INC | $10.36 | $6.91 | 49.93% | 14.39x | 13.02x | 4.61x | 5.68x | 0.84x | $116.47M | 4.92% | $408.21M | 1.79 | $2.38B | 10.22 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $218.42 | $178.52 | 22.35% | 14.31x | 8.55x | 3.00x | 2.95x | 0.59x | $1.62B | 11.73% | $4.80B | 75.98 | $16.95B | 10.49 | ||
| EXEL | EXELIXIS INC | $59.86 | $29.71 | 101.46% | 18.19x | 18.09x | 6.16x | 8.04x | 1.20x | $1.17B | 7.81% | $1.84B | 7.35 | $14.72B | 13.53 | ||
| MDXG | MIMEDX GROUP INC | $4.67 | $1.26 | 270.41% | 116.75x | -26.93x | 1.94x | 3.15x | 1.27x | $44.50M | 6.45% | $216.00M | 1.46 | $562.07M | 24.64 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $301.81 | $85.02 | 255.00% | 29.97x | 31.95x | 20.84x | 6.22x | 2.27x | $130.62M | 2.16% | $967.52M | 48.22 | $6.14B | 22.01 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $510.08 | $146.93 | 247.17% | 29.43x | 26.65x | 10.28x | 6.39x | 2.21x | $3.80B | 2.93% | $20.25B | 79.81 | $125.12B | 22.74 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $40.28 | $29.80 | 35.16% | 12.83x | 9.66x | 2.43x | 2.35x | 0.76x | $354.90M | 15.21% | $999.24M | 17.25 | $1.95B | 6.96 | ||
| UTHR | UNITED THERAPEUTICS CORP | $549.16 | $186.79 | 194.00% | 18.16x | 20.55x | 7.42x | 3.68x | 3.33x | $1.09B | 4.67% | $6.40B | 150.24 | $21.75B | 12.97 | ||
| TECH | BIO-TECHNE CORP | $72.46 | $16.13 | 349.35% | 61.93x | 34.88x | 9.30x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.39B | 32.75 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $746.54 | $423.76 | 76.17% | 17.80x | 13.31x | 4.94x | 2.42x | 0.94x | $3.76B | 4.90% | $31.71B | 308.48 | $77.11B | 13.41 | ||
| VCYT | VERACYTE INC | $45.23 | $11.61 | 289.45% | 31.41x | 23.26x | 6.44x | 2.62x | 2.64x | $165.99M | 4.59% | $1.39B | 17.36 | $3.37B | 24.16 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.20 | $1.37 | -12.70% | 8.57x | -2.70x | 1.48x | 1.58x | 0.48x | $19.58M | 28.17% | $44.20M | 0.76 | $21.15M | 2.77 | ||
| INCY | INCYTE CORP | $112.79 | $58.34 | 93.34% | 13.89x | 31.82x | 3.88x | 3.60x | 1.56x | $1.92B | 8.50% | $6.34B | 31.66 | $18.91B | 9.14 |